Skip to content

The efficacy of herbal ointment in treatment of Anal fissure

Comparison of the TPM therapeutic protocol efficacy in chronic anal fissure with classic treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017010731808N1
Enrollment
60
Registered
2017-03-05
Start date
2017-03-05
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anal fissure. Chronic anal fissure

Interventions

Intervention 1: Intervention group: ITM based protocol local herbal gel from extract of Astragalus fasciculifolius, Comiphora mukul, Syzygium aromaticum:clove, Aloe vera and Allium ampeloprasum, 1
Treatment - Drugs
Intervention group: ITM based protocol local herbal gel from extract of Astragalus fasciculifolius, Comiphora mukul, Syzygium aromaticum:clove, Aloe vera and Allium ampeloprasum, 1 gram BID, and di
Control group: diltigel, 1 gram BID and high fiber diet is recommended for 4 weeks .

Sponsors

Vice Chancellor for Research, Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: female with chronic anal fissure between 20 and 60 years old with pain and irritation; no fistula or abscess in the anal area; no history of anal cancer. Exclusion criterion: patients with underlying diseases (crohn disease, ulcerative colitis ); sensitivity to drug ingredients; pregnancy or lactation.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: Before the start of intervention, 1, 2, 4 weeks after intervention and 4 weeks after the end of intervention. Method of measurement: VAS.

Secondary

MeasureTime frame
Irritation. Timepoint: Before the start of intervention, 1, 2, 4 weeks after intervention and 4 weeks after the end of intervention. Method of measurement: VAS.;Bleeding. Timepoint: Before the start of intervention, 1, 2, 4 weeks after intervention and 4 weeks after the end of intervention. Method of measurement: VAS.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSedigheh Taavakoli Dastjerdi

Mashhad University of Medical Sciences

tavakkolis901@mums.c.ir

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026